A Review of Antiherpetic Medications in Pregnancy to Suppress Erythema Multiforme and Risks of Fetal Harm
Journal of Dermatology Research · 03.08.2026 · 7 (2) · 1-8
DOI: 10.46889/jdr.2026.7213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Dermatology Research, online erschienen am 03.08.2026. Verfasst von Joshua J Weyand und 3 weiteren Autor:innen. Die Arbeit nennt 12 Literaturangaben.
Abstract (Originalsprache)
A review of the literature highlights a 2.2% rate of major fetal birth defects in patients exposed to acyclovir, valacyclovir or famciclovir prophylaxis in the first trimester, comparable to a 2.4% rate in those not exposed to the antiviral therapy in a Danish cohort study. In addition, the literature reveals multiple cases of herpes simplex virus associated erythema multiforme occurring during pregnancy, with a wide array of outcomes including significantly decreased oral intake and as severe as fetal demise. The authors are concerned with the morbidity and mortality of unborn fetuses from mothers with recurrent exacerbations of herpes simplex virus induced erythema multiforme that have not been protected with antiviral therapy. Therefore, the following review was conducted to analyze available evidence regarding the impacts of erythema multiforme on pregnancy and the safety of antiviral therapy in expecting mothers.
Zitieren
APA
Weyand, J. J., Andrzejewski, M. L., Klepper, E. M., & Robinson, H. N. (2026). A Review of Antiherpetic Medications in Pregnancy to Suppress Erythema Multiforme and Risks of Fetal Harm. Journal of Dermatology Research, 7(2), 1-8. https://doi.org/10.46889/jdr.2026.7213
Vancouver
Weyand JJ, Andrzejewski ML, Klepper EM, Robinson HN. A Review of Antiherpetic Medications in Pregnancy to Suppress Erythema Multiforme and Risks of Fetal Harm. Journal of Dermatology Research. 2026;7(2):1-8. doi:10.46889/jdr.2026.7213
BibTeX
@article{Weyand2026,
author = {Weyand, Joshua J and Andrzejewski, Maria L and Klepper, Edward M and Robinson, Howard N},
title = {A Review of Antiherpetic Medications in Pregnancy to Suppress Erythema Multiforme and Risks of Fetal Harm},
journal = {Journal of Dermatology Research},
year = {2026},
volume = {7},
number = {2},
pages = {1--8},
doi = {10.46889/jdr.2026.7213}
}
EUVIMED